MAPK3 and astrocytoma (excluding glioblastoma): Our previous study demonstrated that CIL-102 inhibited proliferation in human astrocytoma cells by activating the ERK1/2 and Cdc25cSer216 cell-cycle-related proteins and inducing ROS production, leading to oxidative stress [23, 24].